Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Makatsoris

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Journal of Neurosurgery|January 10, 2015
Seasonal variability in the incidence of carcinomatous meningitisAngelos Koutras, Minas Sakellakis, Thomas Makatsoris, et al.
Urologia Internationalis|July 11, 2006
A case of chondrosarcoma developing in a recurrent retroperitoneal mass after chemotherapy for testicular germ cell tumorStelios F Assimakopoulos, Angelos Koutras, Panayiota Ravazoula, et al.
Acta Oncologica (Stockholm, Sweden)|July 11, 2008
Irreversible ototoxicity associated with the use of erlotinib in a patient with pancreatic cancerAngelos K Koutras, Nicholas S Mastronikolis, T R Jeffry Evans, et al.
Cancer Chemotherapy and Pharmacology|July 20, 2005
Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG)Christos Christodoulou, Haralambos P Kalofonos, Evangelos Briasoulis, et al.
Oncology|September 5, 2009
Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology GroupChristos A Papadimitriou, Haralambos Kalofonos, Flora Zagouri, et al.
Cancers|March 29, 2023
Small Extracellular Vesicles (sEVs) Biogenesis Molecular Players Are Associated with Clinical Outcome of Colorectal Cancer PatientsAnastasia Kottorou, Foteinos-Ioannis Dimitrakopoulos, Georgia Diamantopoulou, et al.
Anticancer Research|August 6, 2005
Hepatocellular carcinoma in hepatectomized patients: biologic and therapeutic implicationsThomas Makatsoris, Theodore Petsas, Athanassios C Tsamandas, et al.
Mediterranean Journal of Rheumatology|July 18, 2020
Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective studyDimitrios Daoussis, Konstantinos Melissaropoulos, Theodoros Dimitroulas, et al.
Cancers|May 21, 2020
PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) InhibitorsFoteinos-Ioannis Dimitrakopoulos, Achilleas Nikolakopoulos, Anastasia Kottorou, et al.
Translational Oncology|October 19, 2020
NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease developmentAnna Antonacopoulou, Anastasia E Kottorou, Foteinos-Ioannis Dimitrakopoulos, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Journal of Neurosurgery|January 10, 2015
Seasonal variability in the incidence of carcinomatous meningitisAngelos Koutras, Minas Sakellakis, Thomas Makatsoris, et al.
Urologia Internationalis|July 11, 2006
A case of chondrosarcoma developing in a recurrent retroperitoneal mass after chemotherapy for testicular germ cell tumorStelios F Assimakopoulos, Angelos Koutras, Panayiota Ravazoula, et al.
Acta Oncologica (Stockholm, Sweden)|July 11, 2008
Irreversible ototoxicity associated with the use of erlotinib in a patient with pancreatic cancerAngelos K Koutras, Nicholas S Mastronikolis, T R Jeffry Evans, et al.
Cancer Chemotherapy and Pharmacology|July 20, 2005
Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG)Christos Christodoulou, Haralambos P Kalofonos, Evangelos Briasoulis, et al.
Oncology|September 5, 2009
Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology GroupChristos A Papadimitriou, Haralambos Kalofonos, Flora Zagouri, et al.
Cancers|March 29, 2023
Small Extracellular Vesicles (sEVs) Biogenesis Molecular Players Are Associated with Clinical Outcome of Colorectal Cancer PatientsAnastasia Kottorou, Foteinos-Ioannis Dimitrakopoulos, Georgia Diamantopoulou, et al.
Anticancer Research|August 6, 2005
Hepatocellular carcinoma in hepatectomized patients: biologic and therapeutic implicationsThomas Makatsoris, Theodore Petsas, Athanassios C Tsamandas, et al.
Mediterranean Journal of Rheumatology|July 18, 2020
Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective studyDimitrios Daoussis, Konstantinos Melissaropoulos, Theodoros Dimitroulas, et al.
Cancers|May 21, 2020
PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) InhibitorsFoteinos-Ioannis Dimitrakopoulos, Achilleas Nikolakopoulos, Anastasia Kottorou, et al.
Translational Oncology|October 19, 2020
NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease developmentAnna Antonacopoulou, Anastasia E Kottorou, Foteinos-Ioannis Dimitrakopoulos, et al.
Pageof 7